Immunocore Holdings plc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Immunocore Holdings plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q3 2024.
  • Immunocore Holdings plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $8.74M, a 864% increase year-over-year.
  • Immunocore Holdings plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$47M.
  • Immunocore Holdings plc annual Net Income (Loss) Attributable to Parent for 2023 was -$55.3M, a 5.22% decline from 2022.
  • Immunocore Holdings plc annual Net Income (Loss) Attributable to Parent for 2022 was -$52.5M, a 70.8% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$47M $8.74M +$7.83M +864% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$54.9M -$11.6M +$5.4M +31.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$60.3M -$24.4M -$4.99M -25.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$55.3M -$19.7M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $906K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$17M Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$19.4M Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.